AIM ImmunoTech converts $450K of promissory note into 1.92M shares at $0.234/share

AIM ImmunoTech Inc.

Entered two exchange agreements with Streeterville Capital on Sept 3-4, 2026, converting ~$450,000 of Nov 2025 promissory note.
Issued 1,921,441 common shares at average conversion price of ~$0.234 per share.
Stockholders approved conversion at July 15, 2026 special meeting per NYSE American rules.
Original note principal was $3,301,250; exchange reduces outstanding balance by $450,000.
Shares issued under Section 3(a)(9) exemption; no commission paid.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.